Computational Evaluation of Neem-Derived Compounds as FTO Inhibitors for Metabolic Disorder Therapy
Letters in Applied NanoBioScience · 30.06.2026 · 15 (2)
DOI: 10.33263/lianbs152.075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied NanoBioScience, online erschienen am 30.06.2026. Verfasst von Selvaraj Sathyapriya und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The study of fat mass and obesity-associated (FTO) enzymes holds promise for managing metabolic disorders and preventing cancer growth. Neem-derived compounds have shown potential as natural inhibitors of FTO. This study aimed to evaluate the effectiveness of neem-derived chemicals as FTO inhibitors by analyzing their electronic properties, drug-like characteristics, and molecular interactions. Molecular docking simulations were performed to assess the binding affinity of neem-derived compounds with FTO. Drug-likeness was evaluated using Lipinski’s rule of five, and electronic properties were analyzed using HOMO-LUMO energy gaps. Quercetin exhibited the strongest binding affinity (-7.80 kcal/mol) and the most thermodynamically stable binding free energy (-45.749 kcal/mol) due to stabilizing interactions with active site residues HIS320, ARG316, LEU203, and SER229. Nimbidol (-7.70 kcal/mol), Nimbidin (-7.50 kcal/mol), and Gedunin (-7.40 kcal/mol) also demonstrated inhibitory potential. Drug-likeness assessments showed that all compounds, except Azadirachtin, met pharmacokinetic suitability criteria. The significant HOMO-LUMO energy gap in quercetin indicated high molecular stability, reinforcing its potential as a promising drug-like molecule. Neem-derived compounds, especially quercetin, may act as FTO inhibitors and could be developed into plant-based treatments for metabolic disorders, though further biological testing is needed.
Zitieren
APA
Sathyapriya, S., Somala, C. S., Adil, M., Bharathkumar, N., Senthil, R., Saravanan, K. M., & Anand, T. (2026). Computational Evaluation of Neem-Derived Compounds as FTO Inhibitors for Metabolic Disorder Therapy. Letters in Applied NanoBioScience, 15(2). https://doi.org/10.33263/lianbs152.075
Vancouver
Sathyapriya S, Somala CS, Adil M, Bharathkumar N, Senthil R, Saravanan KM, et al. Computational Evaluation of Neem-Derived Compounds as FTO Inhibitors for Metabolic Disorder Therapy. Letters in Applied NanoBioScience. 2026;15(2). doi:10.33263/lianbs152.075
BibTeX
@article{Sathyapriya2026,
author = {Sathyapriya, Selvaraj and Somala, Chaitanya Sree and Adil, Mohamed and Bharathkumar, Nagaraj and Senthil, Renganathan and Saravanan, Konda Mani and Anand, Thirunavukarasou},
title = {Computational Evaluation of Neem-Derived Compounds as FTO Inhibitors for Metabolic Disorder Therapy},
journal = {Letters in Applied NanoBioScience},
year = {2026},
volume = {15},
number = {2},
doi = {10.33263/lianbs152.075}
}
EUVIMED